Tech Company Financing Transactions

Prevail Therapeutics Funding Round

Prevail Therapeutics, based in New York, raised $50 million from AbbVie Biotech Ventures, Adage Capital Management and Alexandria Venture Investments.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds of the financing will be used to advance development of Prevail's pipeline of novel gene therapy programs.

Company Information

Company Status
Acquired or Merged
Mailing Address
430 East 29th St. 1520
New York, NY 10016
Email Address
Prevail Therapeutics is a biotech company based in New York City that is developing therapeutics for brain disorders such as Parkinson's disease. Prevail is establishing a pipeline of programs that includes discovery-phase and preclinical development efforts.
Prevail Therapeutics LinkedIn Company Profile
Social Media
Prevail Therapeutics Company Twitter Account
Company News
Prevail Therapeutics News
Prevail Therapeutics on Facebook
Prevail Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Asa Abeliovich
  Asa Abeliovich LinkedIn Profile  Asa Abeliovich Twitter Account  Asa Abeliovich News  Asa Abeliovich on Facebook
Chief Financial Officer
Brett Kaplan
  Brett Kaplan LinkedIn Profile  Brett Kaplan Twitter Account  Brett Kaplan News  Brett Kaplan on Facebook
Chief Medical Officer
Jeffrey Sevigny
  Jeffrey Sevigny LinkedIn Profile  Jeffrey Sevigny Twitter Account  Jeffrey Sevigny News  Jeffrey Sevigny on Facebook
Chief Technical Officer
Yong Dai
  Yong Dai LinkedIn Profile  Yong Dai Twitter Account  Yong Dai News  Yong Dai on Facebook
VP - Bus. Development
Franz Hefti
  Franz Hefti LinkedIn Profile  Franz Hefti Twitter Account  Franz Hefti News  Franz Hefti on Facebook
VP - Bus. Development
Emily Minkow
  Emily Minkow LinkedIn Profile  Emily Minkow Twitter Account  Emily Minkow News  Emily Minkow on Facebook
VP - General Counsel
Kira Schwartz
  Kira Schwartz LinkedIn Profile  Kira Schwartz Twitter Account  Kira Schwartz News  Kira Schwartz on Facebook



Browse more venture capital transactions:

Prev: 3/28/2019: Boundless Immigration venture capital transaction
Next: 3/28/2019: Spike venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary